Proteins and peptides have become increasingly important in therapeutics due to their high specificity, potency, and the ability to target a wide range of diseases, including cancer, diabetes, and autoimmune disorders. Characterization of these modalities can be challenging due to the complexity of these molecules, manufacturing consideration and interactions with other biomolecules. This webinar will address impurity challenges that arise while manufacturing peptide therapeutics and investigate structural complexities of protein-ligand binding.